AbbVie to sell Allergan Biologics to Pharmaron for $119 million
Abbvie fundamentals
Over the current book year the company from North Chicago could achieve a revenue around 55.36 billion USD (consensus estimates). This is rather significant more than 2020's revenue of 45.8 billion USD.
Historical revenues and results Abbvie plus estimates 2020
Abbvie The analysts expect for 2021 a net profit of 22.12 billion USD. According to most of the analysts the company will have a profit per share for this book year of 12.43 USD. So the price/earnings-ratio equals 8.58.
Huge dividend Abbvie
Per share the analysts anticipate on a dividend of 5.13 USD per share. Thus the dividend yield equals 4.81 percent. The average dividend yield of the biotech companies is a limited 0.37 percent.Based on the current number of shares Abbvie 's market capitalization equals 157.8 billion USD. The Abbvie stock was the past 12 months quite volatile. Since last March the stock is even 26 percent higher. This year the stock price moved between 63 and 113 dollar.
Historical stock prices Abbvie past 10 years
Click here for dividend Abbvie. On Friday, the stock closed at 106.7 USD.
Analist.nl Nieuwsdienst: +31 084-0032-842
nieuws@analist.nl
Copyright analist.nl B.V.
All rights reserved. Any redistribution, duplication or archiving prohibited. Analist.nl doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.
| About us | Network | Partners |
| Fpgroup.nlinfo@analist.nlRSS feedContactIntellectual Property Photos |
Analist.nlLinksISIN
|
MorningstarPrudena.comAAII.comNASDAQvwd GroupEuronextBATS Chi-x
|
